Understanding the role of P2X7 in affective disorders—are glial cells the major players?

Frontiers in Cellular Neuroscience

Volumn 9, Issue JULY, 2015, Pages

  Stokes, Leanne ^a,b   Spencer, Sarah J ^a   Jenkins, Trisha A ^a  

^a RMIT UNIVERSITY   (Australia)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Depression; Inflammation; Microglia; Mouse models; P2X7; SNP

Indexed keywords

ADENOSINE TRIPHOSPHATE; CD11B ANTIGEN; CORTICOSTERONE; CORTICOTROPIN; DOPAMINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; ION CHANNEL; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROTRANSMITTER; NORADRENALIN; PURINERGIC P2X7 RECEPTOR; SEROTONIN; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ANOREXIA; ARTICLE; ASTROCYTE; BIPOLAR DISORDER; CELL POPULATION; DEPRESSION; DISEASE SEVERITY; FORCED SWIM TEST; GENE; GENE DELETION; GLIA CELL; HUMAN; ILLNESS BEHAVIOR; INFLAMMATION; INTRACELLULAR SIGNALING; META ANALYSIS (TOPIC); MICROGLIA; MOOD DISORDER; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PSYCHOSOCIAL WITHDRAWAL; SINGLE NUCLEOTIDE POLYMORPHISM; SLEEP DISORDER; TAIL SUSPENSION TEST;

EID: 84936951050     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2015.00258     Document Type: Article

References (66)

1. Adriouch, S., Dox, C., Welge, V., Seman, M., Koch-Nolte, F., and Haag, F. (2002). Cutting edge: a natural P451L mutation in the cytoplasmic domain impairs the function of the mouse P2X7 receptor. J. Immunol. 169, 4108-4112. doi: 10.4049/jimmunol.169.8.4108
2. Barbera-Cremades, M., Baroja-Mazo, A., Gomez, A. I., Machado, F., Di Virgilio, F., and Pelegrin, P. (2012). P2X7 receptor-stimulation causes fever via PGE2 and IL-1beta release. FASEB J. 26, 2951-2962. doi: 10.1096/fj.12-205765
3. Barden, N., Harvey, M., Gagne, B., Shink, E., Tremblay, M., Raymond, C., et al. (2006). Analysis of single nucleotide polymorphisms in genes in the chromosome 12Q24.31 region points to P2RX7 as a susceptibility gene to bipolar affective disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141B, 374-382. doi: 10.1002/ajmg.b.30303
4. Bartlett, R., Stokes, L., and Sluyter, R. (2014). The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease. Pharmacol. Rev. 66, 638-675. doi: 10.1124/pr.113.008003
5. Bartlett, R., Yerbury, J. J., and Sluyter, R. (2013). P2X7 receptor activation induces reactive oxygen species formation and cell death in murine EOC13 microglia. Mediators Inflamm. 2013:271813. doi: 10.1155/2013/271813
6. Basso, A., Bratcher, N., Harris, R., Jarvis, M., Decker, M., and Rueter, L. (2009). Behavioral profile of P2X7 receptor knockout mice in animal models of depression, anxiety: relevance for neuropsychiatric disorders. Behav. Brain Res. 198, 83-90. doi: 10.1016/j.bbr.2008.10.018
7. Bayer, T. A., Buslei, R., Havas, L., and Falkai, P. (1999). Evidence for activation of microglia in patients with psychiatric illnesses. Neurosci. Lett. 271, 126-128. doi: 10.1016/s0304-3940(99)00545-5
8. Bhattacharya, A., Wang, Q., Ao, H., Shoblock, J. R., Lord, B., Aluisio, L., et al. (2013). Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567, Br. J. Pharmacol. 170, 624-640. doi: 10.1111/bph.12314
9. Boucher, A. A., Arnold, J. C., Hunt, G. E., Spiro, A., Spencer, J., Brown, C., et al. (2011). Resilience and reduced c-Fos expression in P2X7 receptor knockout mice exposed to repeated forced swim test. Neuroscience 189, 170-177. doi: 10.1016/j.neuroscience.2011.05.049
10. Burnstock, G. (2008). Purinergic signalling and disorders of the central nervous system. Nat. Rev. DrugDiscov. 7, 575-590. doi: 10.1038/nrd2605
11. Cao, X., Li, L.-P., Wang, Q., Wu, Q., Hu, H.-H., Zhang, M., et al. (2013). Astrocyte-derived ATP modulates depressive-like behaviors. Nat. Med. 19, 773-777. doi: 10.1038/nm.3162
12. Csolle, C., Andó, R., Kittel, Å., Goloncser, F., Baranyi, M., Soproni, K., et al. (2013a). The absence of P2X7 receptors (P2rx7) on non-haematopoietic cells leads to selective alteration in mood-related behaviour with dysregulated gene expression and stress reactivity in mice. Int. J. Neuropsychopharmacol. 16, 213-233. doi: 10.1017/s1461145711001933
13. Csolle, C., Baranyi, M., Zsilla, G., Kittel, A., Goloncser, F., Illes, P., et al. (2013b). Neurochemical changes in the mouse hippocampus underlying the antidepressant effect of genetic deletion of P2X7 receptors. PLoS One 8:e66547. doi: 10.1371/journal.pone.0066547
14. Cunningham, C., Campion, S., Teeling, J., Felton, L., and Perry, V. H. (2007). The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C). Brain Behav. Immun. 21, 490-502. doi: 10.1016/j.bbi.2006.12.007
15. Dahl, J., Ormstad, H., Aass, H. C., Malt, U. F., Bendz, L. T., Sandvik, L., et al. (2014). The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery. Psychoneuroendocrinology 45, 77-86. doi: 10.1016/j.psyneuen.2014.03.019
16. Dantzer, R. (2009). Cytokine, sickness behavior and depression. Immunol. Allergy Clin. North Am. 29, 247-264. doi: 10.1016/j.iac.2009.02.002
17. Drzyzga, L., Obuchowicz, E., Marcinowska, A., and Herman, Z. S. (2006). Cytokines in schizophrenia and the effects of antipsychotic drugs. Brain Behav. Immun. 20, 532-545. doi: 10.1016/j.bbi.2006.02.002
18. Feng, W.-P., Zhang, B., Li, W., and Liu, J. (2014). Lack of association of P2RX7 gene rs2230912 polymorphism with mood disorders: a meta-analysis. PLoS One 9:e88575. doi: 10.1371/journal.pone.0088575
19. Ferrari, D., Chiozzi, P., Falzoni, S., Hanau, S., and Di Virgilio, F. (1997). Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin. J. Exp. Med. 185, 579-582. doi: 10.1084/jem.185.3.579
20. Ferrari, D., Pizzirani, C., Adinolfi, E., Lemoli, R. M., Curti, A., Idzko, M., et al. (2006). The P2X7 receptor: a key player in IL-1 processing and release. J. Immunol. 176, 3877-3883. doi: 10.4049/jimmunol.176.7.3877
21. Garver, D. L., Tamas, R. L., and Holcomb, J. A. (2003). Elevated interleukin-6 in the cerebrospinal fluid of a previously delineated schizophrenia subtype. Neuropsychopharmacology 28, 1515-1520. doi: 10.1038/sj.npp.1300217
22. Gaughran, F. (2002). Immunity and schizophrenia: autoimmunity, cytokines and immune responses. Int. Rev. Neurobiol. 52, 275-302. doi: 10.1016/s0074-7742(02)52013-4
23. Green, E. K., Grozeva, D., Raybould, R., Elvidge, G., Macgregor, S., Craig, I., et al. (2009). P2RX7: a bipolar and unipolar disorder candidate susceptibility gene? Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B, 1063-1069. doi: 10.1002/ajmg.b.30931
24. Gubert, C., Fries, G., Pfaffenseller, B., Ferrari, P., Coutinho-Silva, R., Morrone, F., et al. (2014). Role ofP2X7 receptor in an animal model of mania induced byD-Amphetamine. Mol. Neurobiol. doi: 10.1007/s12035-014-9031-z [Epub ahead of print].
25. Haarman, B., Doorduin, J., Riemersma-Van Der Lek, R. F., Zandstra, T. E., Drexhage, H. A., and Nolen, W. A. (2014). Neuroinflammation in bipolar disorder? An [11c] PK11195, PET study in euthymic patients. Bipolar Disord.16, 42-42. doi: 10.1016/j.bbi.2014.03.016
26. Halmai, Z., Dome, P., Vereczkei, A., Abdul-Rahman, O., Szekely, A., Gonda, X., et al. (2013). Associations between depression severity and purinergic receptor P2RX7 gene polymorphisms. J. Affect. Disord. 150, 104-109. doi: 10.1016/j.jad.2013.02.033
27. Hansen, T., Jakobsen, K. D., Fenger, M., Nielsen, J., Krane, K., Fink-Jensen, A., et al. (2008). Variation in the purinergic P2RX7 receptor gene and schizophrenia. Schizophr. Res. 104, 146-152. doi: 10.1016/j.schres.2008.05.026
28. Hejjas, K., Szekely, A., Domotor, E., Halmai, Z., Balogh, G., Schilling, B., et al. (2009). Association between depression and the Gln460Arg polymorphism of P2RX7 gene: a dimensional approach. Am. J. Med. Genet. B Neuropsychiatr. Genet. 150B,295-299. doi: 10.1002/ajmg.b.30799
29. Hiles, S. A., Baker, A. L., de Malmanche, T., and Attia, J. (2012). A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: exploring the causes of heterogeneity. Brain Behav. Immun. 26, 1180-1188. doi: 10.1016/j.bbi.2012.06.001
30. Hinwood, M., Morandini, J., Day, T. A., and Walker, F. R. (2012). Evidence that microglia mediate the neurobiological effects of chronic psychological stress on the medial prefrontal cortex. Cereb. Cortex 22, 1442-1454. doi: 10.1093/cercor/bhr229
31. Hope, S., Melle, I., Aukrust, P., Steen, N. E., Birkenaes, A. B., Lorentzen, S., et al. (2009). Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor. Bipolar Disord. 11,726-734. doi: 10.1111/j.1399-5618.2009.00757.x
32. Koshimizu, T.-A., Van Goor, F., Tomic, M., Wong, A. O.-L., Tanoue, A., Tsujimoto, G., et al. (2000). Characterization of calcium signaling by purinergic receptor-channels expressed in excitable cells. Mol. Pharmacol. 58, 936-945. doi: 10.1124/mol.58.5.936
33. Kreisel, T., Frank, M. G., Licht, T., Reshef, R., Ben-Menachem-Zidon, O., Baratta, M. V., et al. (2014). Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis. Mol. Psychiatry 19, 699-709. doi: 10.1038/mp.2013.155
34. Labasi, J. M., Petrushova, N., Donovan, C., McCurdy, S., Lira, P., Payette, M. M., et al. (2002). Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response. J. Immunol. 168, 6436-6445. doi: 10.4049/jimmunol.168.12.6436
35. Liu, Y., Ho, R. C. M., and Mak, A. (2012). Interleukin (IL)-6, tumour necrosis factor alpha (TNF-a) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta­regression. J. Affect. Disord. 139, 230-239. doi: 10.1016/j.jad.2011.08.003
36. Lopez-Castejon, G., Theaker, J., Pelegrin, P., Clifton, A. D., Braddock, M., and Surprenant, A. (2010). P2X7 receptor-mediated release of cathepsins from macrophages is a cytokine-independent mechanism potentially involved in joint diseases. J. Immunol. 185, 2611-2619. doi: 10.4049/jimmunol.1000436
37. Lord, B., Aluisio, L., Shoblock, J. R., Neff, R. A., Varlinskaya, E. I., Ceusters, M., et al. (2014). Pharmacology of a novel central nervous system-penetrant P2X7 antagonist JNJ-42253432, J. Pharmacol. Exp. Ther. 351, 628-641. doi: 10.1124/jpet.114.218487
38. Lucae, S., Salyakina, D., Barden, N., Harvey, M., Gagne, B., Labbe, M., et al. (2006). P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder. Hum. Mol Genet. 15, 2438-2445. doi: 10.1093/hmg/ddl166
39. McQuillin, A., Bass, N., Choudhury, K., Puri, V., Kosmin, M., Lawrence, J., et al. (2009). Case-control studies show that a non-conservative amino-acid change from a glutamine to arginine in the P2RX7 purinergic receptor protein is associated with both bipolar-and unipolar-affective disorders. Mol. Psychiatry 14, 614-620. doi: 10.1038/mp.2008.6
40. Miller, B. J., Buckley, P., Seabolt, W., Mellor, A., and Kirkpatrick, B. (2011). Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol. Psychiatry 70, 663-671. doi: 10.1016/j.biopsych.2011.04.013
41. Mingam, R., De Smedt, V., Amedee, T., Bluthe, R.-M., Kelley, K. W., Dantzer, R., et al. (2008). In vitro and in vivo evidence for a role of the P2X7 receptor in the release ofIL-1β in the murine brain. Brain Behav. Immun. 22, 234-244. doi: 10.1016/j.bbi.2007.08.007
42. Monif, M., Reid, C., Powell, K., Smart, M., and Williams, D. (2009). The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore. J. Neurosci. 29,3781-3791. doi: 10.1523/JNEUR0SCI.5512-08.2009
43. Nagy, G., Ronai, Z., Somogyi, A., Sasvari-Szekely, M., Rahman, O., Mate, A., et al. (2008). P2RX7, Gln460Arg polymorphism is associated with depression among diabetic patients. Prog. Neuropsychopharmacol. Biol. Psychiatry 32, 1884-1888. doi: 10.1016/j.pnpbp.2008.08.021
44. O'Brien, S. M., Scully, P., Scott, L. V., and Dinan, T. G. (2006). Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. J. Affect. Disord. 90, 263-267. doi: 10.1016/j.jad.2005.11.015
45. Pelegrin, P., Barroso-Gutierrez, C., and Surprenant, A. (2008). P2X7 receptor differentially couples to distinct release pathways for IL-1^ in mouse macrophage. J. Immunol. 180, 7147-7157. doi: 10.4049/jimmunol.180.11.7147
46. Pereira, V. S., Casarotto, P. C., Hiroaki-Sato, V. A., Sartim, A. G., Guimaraes, F. S., and Joca, S. R. L. (2013). Antidepressant-and anticompulsive-like effects of purinergic receptor blockade: involvement of nitric oxide. Eur. Neuropsychopharmacol. 23, 1769-1778. doi: 10.1016/j.euroneuro.2013.01.008
47. Radewicz, K., Garey, L. J., Gentleman, S. M., and Reynolds, R. (2000). Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics. J. Neuropathol. Exp. Neurol. 59, 137-150
48. Raison, C. L., Dantzer, R., Kelley, K. W., Lawson, M. A., Woolwine, B. J., Vogt, G., et al. (2010). CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Mol. Psychiatry 15, 393-403. doi: 10.1038/mp.2009.116
49. Rao, J. S., Harry, G. J., Rapoport, S. I., and Kim, H. W. (2010). Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol. Psychiatry 15, 384-392. doi: 10.1038/mp.2009.47
50. Robson, S. C., Sevigny, J., and Zimmermann, H. (2006). The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signal. 2, 409-430. doi: 10.1007/s11302-006-9003-5
51. Sasayama, D., Hattori, K., Wakabayashi, C., Teraishi, T., Hori, H., Ota, M., et al. (2013). Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder. J. Psychiatr. Res. 47, 401-406. doi: 10.1016/j.jpsychires.2012.12.001
52. Shieh, C.-H., Heinrich, A., Serchov, T., van Calker, D., and Biber, K. (2014). P2X7-dependent, but differentially regulated release of IL-6, CCL2 and TNF-a in cultured mouse microglia. Glia 62, 592-607. doi: 10.1002/glia.22628
53. Skaper, S. D., Facci, L., Culbert, A. A., Evans, N. A., Chessell, I., Davis, J. B., et al. (2006). P2X7 receptors on microglial cells mediate injury to cortical neurons in vitro. Glia 54, 234-242. doi: 10.1002/glia.20379
54. Sluyter, R., and Stokes, L. (2011). Significance of P2X7 receptor variants to human health and disease. Recent Pat. DNA Gene Seq. 5, 41-54. doi: 10.2174/187221511794839219
55. Soderlund, J., Olsson, S. K., Samuelsson, M., Walther-Jallow, L., Johansson, C., Erhardt, S., et al. (2011). Elevation of cerebrospinal fluid interleukin-1 |3 in bipolar disorder. J. Psychiatry Neurosci. 36, 114-118. doi: 10.1503/jpn.100080
56. Solle, M., Labasi, J., Perregaux, D. G., Stam, E., Petrushova, N., Koller, B. H., et al. (2001). Altered cytokine production in mice lacking P2X(7) receptors. J. Biol. Chem. 276, 125-132. doi: 10.1074/jbc.m006781200
57. Soronen, P., Mantere, O., Melartin, T., Suominen, K., Vuorilehto, M., Rytsala, H., et al. (2011). P2RX7 gene is associated consistently with mood disorders and predicts clinical outcome in three clinical cohorts. Am. J. Med. Genet. B Neuropsychiatr. Genet. 156, 435-447. doi: 10.1002/ajmg.b.31179
58. Steiner, J., Bielau, H., Brisch, R., Danos, P., Ullrich, O., Mawrin, C., et al. (2008). Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J. Psychiatr. Res. 42, 151-157. doi: 10.1016/j.jpsychires.2006.10.013
59. Stokes, L., Fuller, S., Sluyter, R., Skarratt, K. K., Gu, B. J., and Wiley, J. S. (2010). Two haplotypes of the P2X(7) receptor containing the Ala-348 to Thr polymorphism exhibit a gain-of-function effect and enhanced interleukin-1beta secretion. FASEB J. 24, 2916-2927. doi: 10.1096/fj.09-150862
60. Torres-Platas, S. G., Cruceanu, C., Chen, G. G., Turecki, G., and Mechawar, N. (2014). Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides. Brain Behav. Immun. 42, 50-59. doi: 10.1016/j.bbi.2014.05.007
61. Tynan, R. J., Naicker, S., Hinwood, M., Nalivaiko, E., Buller, K. M., Pow, D. V., et al. (2010). Chronic stress alters the density and morphology ofmicroglia in a subset of stress-responsive brain regions. Brain Behav. Immun. 24, 1058-1068. doi: 10.1016/j.bbi.2010.02.001
62. Viikki, M., Kampman, O., Anttila, S., Illi, A., Setala-Soikkeli, E., Huuhka, M., et al. (2011). P2RX7 polymorphisms Gln460Arg and His155Tyr are not associated with major depressive disorder or remission after SSRI or ECT. Neurosci. Lett. 493, 127-130. doi: 10.1016/j.neulet.2011.02.023
63. Wilkinson, S. M., Gunosewoyo, H., Barron, M. L., Boucher, A., Mcdonnell, M., Turner, P., et al. (2014). The first CNS-Active carborane: a novel P2X7 receptor antagonist with antidepressant activity. ACS Chem. Neurosci. 5, 335-339. doi: 10.1021/cn500054n
64. Yirmiya, R. (1996). Endotoxin produces a depressive-like episode in rats. Brain Res. 711, 163-174. doi: 10.1016/0006-8993(95)01415-2
65. Zemkova, H., Balik, A., Jiang, Y., Kretschmannova, K., and Stojilkovic, S. S. (2006). Roles of purinergic P2X receptors as pacemaking channels and modulators of calcium-mobilizing pathway in pituitary gonadotrophs. Mol Endocrinol. 20, 1423-1436. doi: 10.1210/me.2005-0508
66. Zou, J., Vetreno, R. P., and Crews, F. T. (2012). ATP-P2X7 receptor signaling controls basal and TNFa-stimulated glial cell proliferation. Glia 60, 661-673. doi: 10.1002/glia.22302